Rehabilitation After Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Dec 24

PMID 34944808

Citations 2

Authors

Hartmut Bertz

Affiliations

Soon will be listed here.

Abstract

The general population is getting older and suffer more haematological malignancies despite being physically fit. These malignancies are mainly only curable via an alloHCT, and they are now carried out more frequently. Patients benefit from intensive rehabilitation earlier and may need it repeatedly in cases of severe side effects (e.g., graft-versus-host disease). They can suffer many problems that other cancer patients do not experience, such as severe infections, continued immunosuppression, nutritional restrictions, acute or chronic GvHD, or organ impairments (e.g., lung, eyes). They may also encounter various associated psychological problems, e.g., feeling like a chimera. Rehabilitation centres willing to care for patients after alloHCT should have an experienced multidisciplinary team and should work in close co-operation with the primary transplant centre.

Citing Articles

Feasibility and effects of the telerehabilitation program during hematopoietic stem cell transplantation.

Kim D, Choi J, Kim C, Lee Y, Kim Y, Jo J Medicine (Baltimore). 2025; 104(8):e41591.

PMID: 39993090 PMC: 11856893. DOI: 10.1097/MD.0000000000041591.

Self-care guidelines for patients in the post-hematopoietic stem cell transplantation period: a scoping review.

Nascimento A, Melo J, Soares K, Marinho A, Ribeiro S, Azevedo I Rev Bras Enferm. 2023; 76(4):e20220383.

PMID: 37820135 PMC: 10561929. DOI: 10.1590/0034-7167-2022-0383.

Impact of SARS-CoV-2 pandemic on rehabilitation of patients after high-dose chemotherapy with allogeneic hematopoietic stem cell transplantation: results of a monocentric, retrospective analysis.

Kiefer T, Luders C, Voller H, Daeschlein G J Cancer Res Clin Oncol. 2022; 149(8):4783-4788.

PMID: 36239793 PMC: 9561317. DOI: 10.1007/s00432-022-04403-5.

References

Dimeo F, Bertz H, Finke J, Fetscher S, Mertelsmann R, KEUL J . An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant. 1996; 18(6):1157-60. View

Wolff D, Bertz H, Greinix H, Lawitschka A, Halter J, Holler E . The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland. Dtsch Arztebl Int. 2011; 108(43):732-40. PMC: 3221419. DOI: 10.3238/arztebl.2011.0732. View

Wehrle A, Kneis S, Dickhuth H, Gollhofer A, Bertz H . Endurance and resistance training in patients with acute leukemia undergoing induction chemotherapy-a randomized pilot study. Support Care Cancer. 2018; 27(3):1071-1079. DOI: 10.1007/s00520-018-4396-6. View

Hilgendorf I, Greinix H, Halter J, Lawitschka A, Bertz H, Wolff D . Long-term follow-up after allogeneic stem cell transplantation. Dtsch Arztebl Int. 2015; 112(4):51-8. PMC: 4335490. DOI: 10.3238/arztebl.2015.0051. View

Ullmann A, Schmidt-Hieber M, Bertz H, Heinz W, Kiehl M, Kruger W . Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016; 95(9):1435-55. PMC: 4972852. DOI: 10.1007/s00277-016-2711-1. View

Lindman A, Handberg C, Olesen G, Duijts S . Health-related quality of life and physical functioning in patients participating in a rehabilitation programme, undergoing non-myeloablative allogeneic haematopoietic stem cell transplantation: Outcomes from a single arm longitudinal study. Eur J Cancer Care (Engl). 2021; 30(6):e13478. DOI: 10.1111/ecc.13478. View

Fu J, Raj V, Guo Y . A Guide to Inpatient Cancer Rehabilitation: Focusing on Patient Selection and Evidence-Based Outcomes. PM R. 2017; 9(9S2):S324-S334. PMC: 5736373. DOI: 10.1016/j.pmrj.2017.04.017. View

Tran J, Norder E, Diaz P, Phillips G, Elder P, Devine S . Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012; 18(8):1250-4. PMC: 3378799. DOI: 10.1016/j.bbmt.2012.01.017. View

Lin R, Elko T, Devlin S, Shahrokni A, Jakubowski A, Dahi P . Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplant. 2019; 55(1):157-164. PMC: 6940509. DOI: 10.1038/s41409-019-0654-6. View

10.

Wolff D, Ayuk F, Elmaagacli A, Bertz H, Lawitschka A, Schleuning M . Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Biol Blood Marrow Transplant. 2013; 19(5):767-76. DOI: 10.1016/j.bbmt.2013.01.018. View

11.

Pulewka K, Wolff D, Herzberg P, Greinix H, Heussner P, Mumm F . Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial. J Cancer Res Clin Oncol. 2017; 143(8):1613-1619. DOI: 10.1007/s00432-017-2424-4. View

12.

Leppla L, Schmid A, Valenta S, Mielke J, Beckmann S, Ribaut J . Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study. Support Care Cancer. 2021; 29(12):8045-8057. PMC: 8550349. DOI: 10.1007/s00520-021-06328-0. View

13.

Mayo S, Messner H, Rourke S, Howell D, Victor J, Kuruvilla J . Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplant. 2016; 51(6):841-7. DOI: 10.1038/bmt.2016.2. View

14.

Zeiser R, Blazar B . Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017; 377(22):2167-2179. PMC: 6034180. DOI: 10.1056/NEJMra1609337. View

15.

Stout N, Santa Mina D, Lyons K, Robb K, Silver J . A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 2020; 71(2):149-175. PMC: 7988887. DOI: 10.3322/caac.21639. View

16.

Herzberg P, Lee S, Heussner P, Mumm F, Hilgendorf I, von Harsdorf S . Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplant. 2012; 48(1):129-34. PMC: 4000447. DOI: 10.1038/bmt.2012.83. View

17.

Maehr B, Keilani M, Wiltschke C, Hassler M, Licht T, Marosi C . Cancer rehabilitation in Austria--aspects of Physical Medicine and Rehabilitation. Wien Med Wochenschr. 2016; 166(1-2):39-43. DOI: 10.1007/s10354-015-0414-1. View

18.

Finke J, Bethge W, Schmoor C, Ottinger H, Stelljes M, Zander A . Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol. 2009; 10(9):855-64. DOI: 10.1016/S1470-2045(09)70225-6. View

19.

Wong F, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C . Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood. 2010; 115(12):2508-19. PMC: 2845903. DOI: 10.1182/blood-2009-06-225631. View

20.

Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N . Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood. 2010; 117(9):2604-13. DOI: 10.1182/blood-2010-09-306308. View